This study was undertaken to evaluate the effect of 3D printed polycaprolactone (PCL)/β-tricalcium phosphate (β-TCP) scaffold containing bone demineralized and decellularized extracellular matrix (bdECM) and human recombinant bone morphogenetic protein-2 (rhBMP-2) on bone regeneration. Scaffolds were divided into PCL/β-TCP, PCL/β-TCP/bdECM, and PCL/β-TCP/bdECM/BMP groups. In vitro release kinetics of rhBMP-2 were determined with respect to cell proliferation and osteogenic differentiation. These three reconstructive materials were implanted into 8 mm diameter calvarial bone defect in male Sprague-Dawley rats. Animals were sacrificed four weeks after implantation for micro-CT, histologic, and histomorphometric analyses. The findings obtained...
Critical bone defects are a major clinical challenge in reconstructive bone surgery. Polycaprolacton...
Our aim was to investigate the bone regeneration capacity of powder-type biphasic ceramic scaffold (...
This study investigated a novel drug delivery system (DDS), consisting of polycaprolactone (PCL) or ...
Defect-specific bone regeneration using 3-dimensional (3D) printing of block bone has been developed...
Our strategy entails investigating the influence of varied concentrations (0, 10, 100 and 1000 ng/ml...
In this study, recombinant human bone morphogenetic protein-2 (rhBMP-2) delivery system with slow mo...
Bone formation and growth are crucial for treating bone fractures. Improving bone-reconstruction met...
In this study, a new concept of a 3D-printed scaffold was introduced for the accurate placement of a...
AbstractRecently, 3D printing as effective technology has been highlighted in the biomedical field. ...
The purpose of this study was to compare bone regeneration and space maintaining ability of three-di...
Abstract Background Tissue-engineered bone materials are an effective tool to repair bone defects. I...
The clinical utilization of recombinant human bone morphogenetic protein 2 (rhBMP-2) delivery system...
Three-dimensional printing (3D printing) is a promising technique for producing scaffolds for bone t...
Critical bone defects are a major clinical challenge in reconstructive bone surgery. Polycaprolacton...
The hypothesis of this study was that the extent of bone regeneration could be enhanced by using sca...
Critical bone defects are a major clinical challenge in reconstructive bone surgery. Polycaprolacton...
Our aim was to investigate the bone regeneration capacity of powder-type biphasic ceramic scaffold (...
This study investigated a novel drug delivery system (DDS), consisting of polycaprolactone (PCL) or ...
Defect-specific bone regeneration using 3-dimensional (3D) printing of block bone has been developed...
Our strategy entails investigating the influence of varied concentrations (0, 10, 100 and 1000 ng/ml...
In this study, recombinant human bone morphogenetic protein-2 (rhBMP-2) delivery system with slow mo...
Bone formation and growth are crucial for treating bone fractures. Improving bone-reconstruction met...
In this study, a new concept of a 3D-printed scaffold was introduced for the accurate placement of a...
AbstractRecently, 3D printing as effective technology has been highlighted in the biomedical field. ...
The purpose of this study was to compare bone regeneration and space maintaining ability of three-di...
Abstract Background Tissue-engineered bone materials are an effective tool to repair bone defects. I...
The clinical utilization of recombinant human bone morphogenetic protein 2 (rhBMP-2) delivery system...
Three-dimensional printing (3D printing) is a promising technique for producing scaffolds for bone t...
Critical bone defects are a major clinical challenge in reconstructive bone surgery. Polycaprolacton...
The hypothesis of this study was that the extent of bone regeneration could be enhanced by using sca...
Critical bone defects are a major clinical challenge in reconstructive bone surgery. Polycaprolacton...
Our aim was to investigate the bone regeneration capacity of powder-type biphasic ceramic scaffold (...
This study investigated a novel drug delivery system (DDS), consisting of polycaprolactone (PCL) or ...